Canada Partners / France Partners / United Kingdom Partners / Israel Partners / Netherlands Partners / /
Country
Switzerland / Sweden / Poland / Canada / United Kingdom / /
Facility
Bar-llan University / University of British Columbia / Tel Aviv University / University Paris Sud / Swiss Federal Institute of Technology Lausanne / Norwegian University of Science / Newcastle University / University of Copenhagen / Umeå University / McMaster University / University of Nottingham / University of Warwick / University of Amsterdam / University of Laval / Uppsala University / Institute of Bioorganic Chemistry / VU University medical center / Paris-Sud University / /
Institut Pasteur / Centre National / McMaster University / TBsec / Newcastle University / Bar-llan University / Polish Academy of Sciences / Universitat Politecnica de Catalunya / University of Amsterdam / University of Nottingham / Tel Aviv University / Paris-Sud University / University of Warwick / Uppsala University / University of Copenhagen / Umeå University / University of British Columbia / Swiss Federal Institute of Technology Lausanne / Norwegian University of Science and Technology / Institute of Bioorganic Chemistry / University of Laval / /
Person
Gregory Challis / Roland Brosch / Horacio Bach / Peter Nielsen / Natalie Strynadka / John McKinney / Roger Levesque / Bogdan Iorga / Mariel Pikkemaat / Stewart Cole / Michel Arthur / Julian Davies / Charles Thompson / Miguel Camara / Jean-Pierre Simorre / /
Granted projects from the first JPIAMR transnational call InnovaResistance: Innovative approaches to address antibacterial resistance Non-conventional approaches for peptidoglycan cross-linking inhibition Peptidoglycan (